- Home
- CIG vs PCVX Comparison
CIG vs PCVX Comparison
Compare CIG & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CIG | PCVX |
|---|---|---|
| Founded | 1952 | 2013 |
| Country | Brazil | United States |
| Employees | 5028 | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6B | 7.0B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | CIG | PCVX |
|---|---|---|
| Price | $2.10 | $49.56 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $88.25 |
| AVG Volume (30 Days) | ★ 7.0M | 1.4M |
| Earning Date | 04-17-2026 | 05-07-2026 |
| Dividend Yield | ★ 6.73% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.49 | N/A |
| P/E Ratio | $9.38 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.79 | $29.10 |
| 52 Week High | $2.76 | $65.00 |
Technical Indicators
Market Signals| Indicator | CIG | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 38.84 | 49.30 |
| Support Level | $2.02 | $48.49 |
| Resistance Level | $2.15 | $52.00 |
| Average True Range (ATR) | 0.05 | 1.92 |
| MACD | 0.01 | 0.34 |
| Stochastic Oscillator | 40.54 | 66.27 |
Price Performance
Historical ComparisonAbout CIG Comp En De Mn Cemig ADS
Cia Energetica DE Minas Gerais - Cemig, formerly Energy Company of Minas Gerais, is a Brazilian power company that generates, transmits, and distributes electricity. As one of the power companies in Brazil, the firm operates across Brazilian states and Chile. The company has various subsidiaries and operates chiefly through its generation, transmission, distribution, and gas segments. The majority of the company's revenue is derived from electricity sales to consumers. The company generates power through hydroelectric resources and, secondarily, through thermal and wind resources.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.